Estadiamento da doença renal crónica

Autores

• José Ramôa University Institute of Health Sciences, Advanced Polytechnic and University Cooperative (CESPU), CRL, 4585-116 Gandra, Portugal.
• Irina Lousa UCIBIO Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal. Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal.
• Sofia Viana Institute of Pharmacology & Experimental Therapeutics, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, CNC.IBILI Consortium & CIBB Consortium, University of Coimbra, Coimbra, Portugal. Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Pharmacy, Portugal.
• Flávio Reis Institute of Pharmacology & Experimental Therapeutics, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, CNC.IBILI Consortium & CIBB Consortium, University of Coimbra, Coimbra, Portugal.
• Luís Belo UCIBIO Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal. Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal.
• Alice Santos-Silva UCIBIO Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal. Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal.
• Susana Coimbra UCIBIO Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal. Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal. TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.